Avillion LLP

Activities: Research & Development

Trending Articles

  1. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Dickson achieves ISO 14001 certification ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
  5. The key role of IVDs in healthcare: challenges to commercialisation and access In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Finance

Avillion appoints Kathryn J. Gregory as Chief Business Officer
Regulatory

US FDA and EMA accept submission of BOSULIF for CML treatment

Applications seek to expand approved use of BOSULIF into first-line treatment based on positive results from Phase 3 head-to-head trial
Pharmaceutical

Nanobodies could lead to a new generation of biological drugs

Avillion signs clinical co-development agreement with Merck to advance Anti IL-17 A/F Nanobody in psoriasis
Finance

Avillion appoints Mark Weinberg as Chief Medical Officer

Mark Weinberg will be based in Chicago as CMO for co-developer and financier of late-stage pharmaceutical product candidates
Research & Development

Jarrod Longcor joins Avillion as Chief Business Officer

Will take responsibility for negotiating co-development agreements and financial investments
Research & Development

Dr Allison Jeynes-Ellis becomes Chief Executive at Avillion

Founding member of management team and formerly Chief Medical Officer at the company
Subscribe now